National Health (Listed drugs on F1 or F2) Amendment Determination 2016 (No. 3) (PB 26 of 2016) (Cth)

PB 26 of 2016

National Health (Listed drugs on F1 or F2) Amendment Determination 2016 (No. 3)

National Health Act 1953

I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated    30     March 2016

ADRIANA PLATONA

Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health

Part 1         Preliminary

1. Name of Determination

   (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2016 (No. 3).

   (2)   This Determination may also be cited as PB 26 of 2016.

2. Commencement

   This Determination commences on 1 April 2016.

3. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

   Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without phenylalanine and tyrosine and supplemented with docosahexanoic acid

Insert

Amino acid formula with fat, carbohydrate without phenylalanine

[2]     Schedule 1, after item dealing with Ciclesonide

Insert

Citrulline

[3]     Schedule 1, after item dealing with Minoxidil

Omit

Modafinil

[4]     Schedule 1, after item dealing with Mupirocin

Insert

Nadroparin

[5]     Schedule 2, after item dealing with Moclobemide

Insert

Modafinil